Navigation Links
VIVUS Provides Regulatory Update on QNEXA
Date:9/15/2011

MOUNTAIN VIEW, Calif., Sept. 15, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that following a recent teleconference it has reached agreement with officials of the Endocrine and Metabolic Division of the Food and Drug Administration on a plan that allows for an early resubmission of the QNEXA New Drug Application for the treatment of obesity. The resubmission plan allows VIVUS to seek approval for an initial indication that includes obese men and women of non-child bearing potential.  Based on this agreement, VIVUS intends to resubmit the QNEXA NDA by the end of October 2011, prior to completion of the FORTRESS study. Top-line results from FORTRESS are expected in December 2011, with validation of FORTRESS expected in the third quarter of 2012. The FDA also stated that an Advisory Committee meeting for QNEXA will be held in the first quarter of 2012.

"Recent epidemiology study results, which show that topiramate is not a major teratogen, were an important consideration in our plan to resubmit the QNEXA NDA ahead of the FORTRESS results. The planned October resubmission will also allow for an early 2012 Advisory Committee meeting and a second quarter 2012 PDUFA date," commented Peter Y. Tam, president of VIVUS. "In this initial indication, we plan to include a contraindication for women of childbearing potential. We believe this is a sound approach that, if approved, will potentially allow early commercialization in a higher-risk population with a significant unmet medical need.  The FORTRESS study remains important in our plan to more precisely define the teratogenic potential of topiramate and may enable us to expand the indication to include obese women of child-bearing potential.  If the FORTRESS results are favorable, we expect to file for the full indication in late 2012."

According to the CDC, over 108 million adult Americans are
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
2. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
3. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
4. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
5. VIVUS to Present at Three Upcoming Investor Conferences in March
6. VIVUS Provides Regulatory Update on QNEXA NDA
7. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
8. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
9. VIVUS to Present at Two Upcoming Investor Conferences
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Every day, their baby ... air to his lungs. April and Bryan Gionfriddo ... predictions weren,t true. "Quite a few doctors said ... alive," says April Gionfriddo , about her ... Anything that would work, we would take it and run ...
(Date:5/23/2013)... May 23, 2013   Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...
(Date:5/23/2013)... 2013 Israel Brain Technologies (IBT) has ... Israel,s 1 st International Brain Technology ... th in Tel Aviv , recently ... the world by the Wall Street Journal and ... 2013 will showcase the latest breakthroughs in neuroscience and brain ...
Breaking Medicine Technology:Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... , GREEN BAY, Wis., Dec. 16 ... DolCas Biotech for the use of super absorbency ... EuroPharma formulations. The exclusive distribution territory for ... store channel and professional channel, which includes allopathic ...
... , , , ... Claims and Clearinghouse Service in the 2009 Top 20 ... RealMed is a dynamic revenue cycle management solution providing advanced, ... payers. KLAS is an independent research firm specializing in ...
Cached Medicine Technology:EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 2RealMed Ranked as 2009 'Best in KLAS' Claims and Clearinghouse Service 3
(Date:5/25/2013)... Ayurveda is the traditional medicine of ... of life". While a medical science, its scope enters into ... Its fundamental philosophy is that disease is the end result ... that in order to re-establish optimal health, we must discover ... a life style which brings us back into harmony. , ...
(Date:5/25/2013)... 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , ... judge's overturning of a jury's award of $6.5 million ... trial* in the country over allegations that the diabetes ... files. , The judge in the case ruled that ... his cancer was caused by the medication.** , Bloomberg ...
(Date:5/24/2013)... A recent study by research group Harris ... upcoming bathing suit season. Almost 138 million people are fearful ... due to weight issues and a quarter admit they feel ... Labs recommends that those anxious about their size consider the ... of an overall effort to improve diet and exercise habits ...
(Date:5/24/2013)... ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On ... on their popular PhenObestin 37.5 non-prescription diet pill. ... weight as effortlessly as possible has reduced the price ... , Bottles have been reduced from $149 to just ... receive free shipping. , Made from a completely ...
(Date:5/24/2013)... Atlanta, GA (PRWEB) May 24, 2013 Before you ... a cup of coffee with Kathie Lee Gifford and Hoda Kotb ... http://www.digitwirl.com , will show cool tech ideas to Kathie Lee and ... Kyodo America honors our brave men and women in the military ... get ready for the BBQ, spend time with friends and family ...
Breaking Medicine News(10 mins):Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:LawnBott® Visits the Today Show with Kathie Lee and Hoda 2
... sees the presentation of a study that, for the ... attached to titanium implants in the bones of patients ... function and quality of life in nine out of ... out at the Sahlgrenska Academy and Sahlgrenska University Hospital ...
... their condition improved after they received a simple and non-invasive ... issue of the European Journal of Neurology . ... Egypt, studied 60 patients with ischaemic stroke - where the ... been left with mild to moderate muscle weakness down one ...
... 74 years who have low baseline blood levels of prostate ... screening and treatment. That is the conclusion of a new ... journal of the American Cancer Society. The aim of the ... and cons of prostate cancer screening and early detection. ...
... Scientists from The Scripps Research Institute have solved a long-standing ... effects of a certain kind of error in protein production. The ... neurodegenerative diseases. The research was published in an advance, online ... "It is exciting because we are dealing not only with ...
... Sept. 10 (HealthDay News) -- For patients aged 70 and older ... reopen the artery is riskier than surgically widening the artery, a ... be a viable option, the researchers say. The carotid arteries, ... of blood to the brain. When they become blocked or narrowed ...
... Education (AGHE) the educational branch of The ... Ansello, PhD, of Virginia Commonwealth University as the newest recipient ... for an AGHE founder, was established in 1980 to recognize ... the advancement of gerontology as a field of study in ...
Cached Medicine News:Health News:Bone-anchored leg prostheses improve quality of life 2Health News:Brain stimulation can help partially paralyzed stroke patients regain use of their muscles 2Health News:Early prostate cancer detection, screening: No benefit for men with low baseline PSA value 2Health News:Scripps Research scientists solve long-standing mystery of protein 'quality control' mechanism 2Health News:Scripps Research scientists solve long-standing mystery of protein 'quality control' mechanism 3Health News:Stenting Riskier for Older Patients With Blocked Carotid Artery 2Health News:Stenting Riskier for Older Patients With Blocked Carotid Artery 3
... ISOLA/VSP Spine System is a comprehensive and ... can be used for both deformity and ... of the spine in 3-dimensions, the ISOLA/VSP ... techniques to correctly align and stabilize the ...
Multiwindow transcranial and peripheral doppler system....
Transcranial and peripheral vascular doppler system....
Transcranial & peripheral vascular doppler system....
Medicine Products: